Share Price and Basic Stock Data
Last Updated: November 8, 2025, 4:20 am
| PEG Ratio | 0.32 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ugro Capital Ltd operates in the finance and investments sector, showcasing a significant growth trajectory in its revenue. For the fiscal year ending March 2025, the company reported revenues of ₹1,396 Cr, a substantial increase from ₹684 Cr in March 2023. This growth is indicative of a robust operational framework, reflected in the quarterly revenues which have shown a consistent upward trend, culminating in ₹322 Cr in March 2024 and further rising to ₹403 Cr in June 2025. The revenue generated from operations per share also increased to ₹151.82 in March 2025, up from ₹94.70 a year earlier. This growth trajectory positions Ugro Capital favorably within the finance sector, which typically sees moderate growth rates, suggesting a competitive edge over peers.
Profitability and Efficiency Metrics
Ugro Capital’s profitability metrics indicate a strengthening financial position, with a net profit of ₹144 Cr reported for the fiscal year ending March 2025, compared to ₹40 Cr in March 2023. This represents a remarkable growth in net profit margins, which stood at 10.31% in March 2025, up from 6.05% the previous year. The return on equity (ROE) was reported at 8.26%, demonstrating effective utilization of shareholders’ funds. The interest coverage ratio (ICR) of 1.40x signals adequate earnings to cover interest obligations. However, the financing margin percentage, which decreased to 15% in March 2025 from 20% in March 2024, suggests potential pressure on profit margins due to rising interest expenses. Overall, while profitability has improved, maintaining margins will be crucial as competition intensifies.
Balance Sheet Strength and Financial Ratios
Ugro Capital’s balance sheet reflects a solid foundation with total assets of ₹9,168 Cr as of March 2025, increasing from ₹4,306 Cr in March 2023. The company’s reserves rose significantly to ₹1,954 Cr, indicating a strong retained earnings position. The debt-to-equity ratio stood at 3.37x, suggesting a leveraged position, which may raise concerns about financial stability in volatile market conditions. Additionally, the price-to-book value ratio at 0.73x indicates that the stock is trading below its intrinsic value, potentially appealing to value investors. However, the current ratio of 1.27x reflects a tighter liquidity position compared to the previous year, which could pose challenges in meeting short-term obligations. Overall, while Ugro Capital demonstrates robust growth, its high leverage may necessitate careful management to mitigate risks.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ugro Capital reveals a diversified investor base, with FIIs holding 29.32% and the public holding 64.69% as of June 2025. This broad distribution suggests a healthy level of investor confidence, particularly as institutional investors have increased their stakes from 6.95% in March 2023 to 29.32% by June 2025. Promoter holdings have remained stable at 2.25%, reflecting commitment from the management. However, the decline in DII holdings to 1.62% from 2.02% over the same period may indicate cautious sentiment among domestic institutional investors. The increase in the number of shareholders to 42,370 signals growing retail interest, which is a positive indicator of market perception. Overall, the shareholder composition reflects a mix of confidence and caution, which could influence future stock performance.
Outlook, Risks, and Final Insight
Looking ahead, Ugro Capital’s growth trajectory in revenue and profitability suggests a positive outlook, particularly if it can maintain its momentum amidst competitive pressures. Key strengths include its robust revenue growth and improved profit margins, which position it favorably in the finance sector. However, risks such as high leverage and potential pressure on financing margins could impact financial stability. The company’s ability to manage its debt levels and sustain profitability in a rising interest rate environment will be critical. Furthermore, fluctuations in investor sentiment, particularly from institutional investors, may affect stock performance. Ugro Capital must navigate these challenges effectively to sustain its growth and deliver value to shareholders.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ugro Capital Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.6 Cr. | 43.0 | 67.7/36.4 | 50.4 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,419 Cr. | 305 | 484/280 | 15.7 | 102 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.14 Cr. | 8.36 | 12.6/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 30.3 Cr. | 58.9 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,983.10 Cr | 1,374.58 | 108.16 | 3,835.00 | 0.32% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117 | 149 | 182 | 209 | 213 | 245 | 268 | 322 | 291 | 330 | 371 | 403 | 414 |
| Interest | 53 | 69 | 82 | 90 | 93 | 105 | 117 | 128 | 136 | 143 | 167 | 181 | 205 |
| Expenses | 57 | 64 | 81 | 87 | 82 | 99 | 107 | 136 | 113 | 139 | 152 | 161 | 156 |
| Financing Profit | 7 | 16 | 19 | 32 | 38 | 41 | 44 | 58 | 43 | 48 | 52 | 61 | 53 |
| Financing Margin % | 6% | 11% | 11% | 15% | 18% | 17% | 16% | 18% | 15% | 15% | 14% | 15% | 13% |
| Other Income | 5 | 6 | 8 | 8 | 5 | 9 | 12 | 8 | 10 | 13 | 14 | 9 | 8 |
| Depreciation | 2 | 5 | 5 | 6 | 8 | 9 | 9 | 10 | 10 | 11 | 12 | 13 | 13 |
| Profit before tax | 10 | 18 | 22 | 34 | 36 | 41 | 46 | 56 | 43 | 50 | 53 | 57 | 48 |
| Tax % | 29% | 70% | 41% | 58% | 29% | 29% | 30% | 42% | 29% | 29% | 29% | 29% | 29% |
| Net Profit | 7 | 5 | 13 | 14 | 25 | 29 | 33 | 33 | 30 | 36 | 38 | 41 | 34 |
| EPS in Rs | 0.82 | 0.59 | 1.47 | 1.57 | 2.16 | 2.47 | 2.78 | 2.78 | 2.58 | 3.02 | 3.18 | 3.44 | 2.92 |
| Gross NPA % | 1.70% | 1.70% | 1.70% | 2.46% | 1.80% | 1.90% | 2.00% | 2.00% | 2.00% | 2.10% | 2.10% | 2.30% | |
| Net NPA % | 1.20% | 1.20% | 1.10% | 1.31% | 1.00% | 1.10% | 1.10% | 1.10% | 1.20% | 1.30% | 1.50% | 1.60% |
Last Updated: August 20, 2025, 1:55 am
Below is a detailed analysis of the quarterly data for Ugro Capital Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Interest, as of Jun 2025, the value is 205.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Mar 2025) to 205.00 Cr., marking an increase of 24.00 Cr..
- For Expenses, as of Jun 2025, the value is 156.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 161.00 Cr. (Mar 2025) to 156.00 Cr., marking a decrease of 5.00 Cr..
- For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 9.00 Cr..
- For Tax %, as of Jun 2025, the value is 29.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00%.
- For Net Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.92. The value appears to be declining and may need further review. It has decreased from 3.44 (Mar 2025) to 2.92, marking a decrease of 0.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 2 | 4 | 2 | 4 | 44 | 105 | 153 | 312 | 684 | 1,082 | 1,396 | 1,518 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 45 | 137 | 293 | 443 | 628 | 697 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 36 | 81 | 85 | 142 | 289 | 425 | 565 | 607 |
| Financing Profit | 5 | 2 | 3 | 2 | 3 | 7 | 11 | 24 | 33 | 101 | 214 | 204 | 214 |
| Financing Margin % | 86% | 76% | 92% | 86% | 91% | 16% | 10% | 16% | 10% | 15% | 20% | 15% | 14% |
| Other Income | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | 46 | 44 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 12 | 12 | 18 | 35 | 46 | 49 |
| Profit before tax | 5 | 2 | 3 | 2 | 3 | 2 | 3 | 12 | 20 | 84 | 179 | 203 | 208 |
| Tax % | 30% | 7% | 14% | 2% | 8% | -155% | -488% | -137% | 28% | 53% | 33% | 29% | |
| Net Profit | 4 | 2 | 3 | 2 | 3 | 4 | 20 | 29 | 15 | 40 | 119 | 144 | 148 |
| EPS in Rs | 6.41 | 2.83 | 5.07 | 3.34 | 5.05 | 1.34 | 2.19 | 3.22 | 1.63 | 4.46 | 10.17 | 12.22 | 12.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 50.00% | -33.33% | 50.00% | 33.33% | 400.00% | 45.00% | -48.28% | 166.67% | 197.50% | 21.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -83.33% | 83.33% | -16.67% | 366.67% | -355.00% | -93.28% | 214.94% | 30.83% | -176.49% |
Ugro Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 89% |
| 5 Years: | 68% |
| 3 Years: | 65% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 49% |
| 3 Years: | 115% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 14% |
| 3 Years: | -2% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: May 13, 2025, 2:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 23 | 71 | 71 | 71 | 69 | 92 | 92 |
| Reserves | 23 | 25 | 27 | 29 | 32 | 796 | 851 | 882 | 896 | 915 | 1,347 | 1,954 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 24 | 255 | 766 | 1,802 | 3,149 | 4,653 | 6,904 |
| Other Liabilities | 1 | 0 | 0 | 0 | 0 | 26 | 36 | 37 | 86 | 173 | 188 | 218 |
| Total Liabilities | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 20 | 38 | 36 | 56 | 85 | 130 | 168 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 4 | 6 | 14 | 0 | 0 |
| Investments | 26 | 15 | 25 | 26 | 36 | 107 | 73 | 55 | 69 | 60 | 59 | 103 |
| Other Assets | 3 | 14 | 8 | 8 | 1 | 731 | 1,101 | 1,659 | 2,724 | 4,146 | 6,091 | 8,897 |
| Total Assets | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 |
Below is a detailed analysis of the balance sheet data for Ugro Capital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 92.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 92.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,954.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,347.00 Cr. (Mar 2024) to 1,954.00 Cr., marking an increase of 607.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 218.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 188.00 Cr. (Mar 2024) to 218.00 Cr., marking an increase of 30.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 9,168.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,280.00 Cr. (Mar 2024) to 9,168.00 Cr., marking an increase of 2,888.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 168.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 38.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 103.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2024) to 103.00 Cr., marking an increase of 44.00 Cr..
- For Other Assets, as of Mar 2025, the value is 8,897.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,091.00 Cr. (Mar 2024) to 8,897.00 Cr., marking an increase of 2,806.00 Cr..
- For Total Assets, as of Mar 2025, the value is 9,168.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,280.00 Cr. (Mar 2024) to 9,168.00 Cr., marking an increase of 2,888.00 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 12.00 | -174.00 | -681.00 | 141.00 | 286.00 | 421.00 | 559.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 15% | 6% | 10% | 6% | 8% | 1% | 2% | 3% | 2% | 4% | 10% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.68 | 13.39 | 5.69 | 2.06 | 4.07 |
| Diluted EPS (Rs.) | 14.71 | 13.20 | 5.66 | 2.05 | 4.07 |
| Cash EPS (Rs.) | 20.70 | 16.89 | 8.28 | 3.81 | 5.74 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Revenue From Operations / Share (Rs.) | 151.82 | 114.42 | 94.70 | 43.55 | 21.24 |
| PBDIT / Share (Rs.) | 95.41 | 71.73 | 56.94 | 24.08 | 9.70 |
| PBIT / Share (Rs.) | 90.37 | 67.88 | 54.40 | 22.33 | 8.04 |
| PBT / Share (Rs.) | 22.09 | 19.52 | 12.09 | 2.86 | 1.72 |
| Net Profit / Share (Rs.) | 15.65 | 13.03 | 5.74 | 2.06 | 4.07 |
| PBDIT Margin (%) | 62.84 | 62.69 | 60.13 | 55.29 | 45.67 |
| PBIT Margin (%) | 59.52 | 59.32 | 57.44 | 51.27 | 37.84 |
| PBT Margin (%) | 14.55 | 17.05 | 12.76 | 6.56 | 8.09 |
| Net Profit Margin (%) | 10.31 | 11.38 | 6.05 | 4.73 | 19.17 |
| Return on Networth / Equity (%) | 7.03 | 8.29 | 4.04 | 1.50 | 3.01 |
| Return on Capital Employeed (%) | 38.12 | 20.96 | 17.06 | 9.25 | 4.50 |
| Return On Assets (%) | 1.56 | 1.90 | 0.92 | 0.50 | 1.64 |
| Long Term Debt / Equity (X) | 0.00 | 0.99 | 1.16 | 0.72 | 0.31 |
| Total Debt / Equity (X) | 3.37 | 3.24 | 3.20 | 1.86 | 0.80 |
| Asset Turnover Ratio (%) | 0.18 | 0.19 | 0.18 | 0.13 | 0.10 |
| Current Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Quick Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Interest Coverage Ratio (X) | 1.40 | 1.48 | 1.35 | 1.24 | 1.54 |
| Interest Coverage Ratio (Post Tax) (X) | 1.23 | 1.27 | 1.14 | 1.11 | 1.64 |
| Enterprise Value (Cr.) | 7869.00 | 6209.26 | 3942.28 | 2792.18 | 1301.28 |
| EV / Net Operating Revenue (X) | 5.64 | 5.92 | 6.01 | 9.09 | 8.69 |
| EV / EBITDA (X) | 8.97 | 9.45 | 9.99 | 16.43 | 19.02 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| Price / BV (X) | 0.73 | 1.40 | 1.02 | 1.22 | 0.89 |
| Price / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| EarningsYield | 0.09 | 0.05 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Ugro Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has increased from 13.39 (Mar 24) to 15.68, marking an increase of 2.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.71. This value is within the healthy range. It has increased from 13.20 (Mar 24) to 14.71, marking an increase of 1.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 20.70. This value is within the healthy range. It has increased from 16.89 (Mar 24) to 20.70, marking an increase of 3.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 151.82. It has increased from 114.42 (Mar 24) to 151.82, marking an increase of 37.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 95.41. This value is within the healthy range. It has increased from 71.73 (Mar 24) to 95.41, marking an increase of 23.68.
- For PBIT / Share (Rs.), as of Mar 25, the value is 90.37. This value is within the healthy range. It has increased from 67.88 (Mar 24) to 90.37, marking an increase of 22.49.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.09. This value is within the healthy range. It has increased from 19.52 (Mar 24) to 22.09, marking an increase of 2.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.65. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 15.65, marking an increase of 2.62.
- For PBDIT Margin (%), as of Mar 25, the value is 62.84. This value is within the healthy range. It has increased from 62.69 (Mar 24) to 62.84, marking an increase of 0.15.
- For PBIT Margin (%), as of Mar 25, the value is 59.52. This value exceeds the healthy maximum of 20. It has increased from 59.32 (Mar 24) to 59.52, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 17.05 (Mar 24) to 14.55, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 10.31. This value exceeds the healthy maximum of 10. It has decreased from 11.38 (Mar 24) to 10.31, marking a decrease of 1.07.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 8.29 (Mar 24) to 7.03, marking a decrease of 1.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 38.12. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 38.12, marking an increase of 17.16.
- For Return On Assets (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has decreased from 1.90 (Mar 24) to 1.56, marking a decrease of 0.34.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.99 (Mar 24) to 0.00, marking a decrease of 0.99.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 1. It has increased from 3.24 (Mar 24) to 3.37, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has decreased from 0.19 (Mar 24) to 0.18, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 3. It has decreased from 1.48 (Mar 24) to 1.40, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 3. It has decreased from 1.27 (Mar 24) to 1.23, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,869.00. It has increased from 6,209.26 (Mar 24) to 7,869.00, marking an increase of 1,659.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.64. This value exceeds the healthy maximum of 3. It has decreased from 5.92 (Mar 24) to 5.64, marking a decrease of 0.28.
- For EV / EBITDA (X), as of Mar 25, the value is 8.97. This value is within the healthy range. It has decreased from 9.45 (Mar 24) to 8.97, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For Price / BV (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.73, marking a decrease of 0.67.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ugro Capital Ltd:
- Net Profit Margin: 10.31%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 38.12% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.9 (Industry average Stock P/E: 108.16)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.31%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | Equinox Business Park, Mumbai Maharashtra 400070 | cs@ugrocapital.com http://www.ugrocapital.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Satyananda Mishra | Non Exe.Chairman&Ind.Director |
| Mr. Shachindra Nath | Vice Chairman & Mng.Director |
| Mr. Karuppasamy Singam | Independent Director |
| Ms. Tabassum Abdulla Inamdar | Independent Director |
| Mr. Karnam Sekar | Independent Director |
| Mr. Hemant Bhargava | Independent Director |
| Mr. Rajeev K Agarwal | Independent Director |
| Mr. Suresh Eshwara Prabhala | Non Exe. & Nominee Director |
| Mr. Rohit Goyal | Non Exe. & Nominee Director |
| Mr. Chetan Gupta | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Ugro Capital Ltd?
Ugro Capital Ltd's intrinsic value (as of 09 November 2025) is 226.13 which is 27.76% higher the current market price of 177.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,475 Cr. market cap, FY2025-2026 high/low of 255/142, reserves of ₹1,954 Cr, and liabilities of 9,168 Cr.
What is the Market Cap of Ugro Capital Ltd?
The Market Cap of Ugro Capital Ltd is 2,475 Cr..
What is the current Stock Price of Ugro Capital Ltd as on 09 November 2025?
The current stock price of Ugro Capital Ltd as on 09 November 2025 is 177.
What is the High / Low of Ugro Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ugro Capital Ltd stocks is 255/142.
What is the Stock P/E of Ugro Capital Ltd?
The Stock P/E of Ugro Capital Ltd is 15.9.
What is the Book Value of Ugro Capital Ltd?
The Book Value of Ugro Capital Ltd is 211.
What is the Dividend Yield of Ugro Capital Ltd?
The Dividend Yield of Ugro Capital Ltd is 0.00 %.
What is the ROCE of Ugro Capital Ltd?
The ROCE of Ugro Capital Ltd is 11.0 %.
What is the ROE of Ugro Capital Ltd?
The ROE of Ugro Capital Ltd is 8.26 %.
What is the Face Value of Ugro Capital Ltd?
The Face Value of Ugro Capital Ltd is 10.0.